EDP-20

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEDP-20
Drug Alias Namecis-[Pt(II)(NH3)2(malSAHAH)]platinum-based HDAC inhibitors (Royal College of Surgeons in Ireland/BioLineRx)EDP-20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitorsDNA intercalators
TargetsHistone deacetylaseDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIrelandIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoyal College Of Surgeons In Ireland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdRoyal College Of Surgeons In Ireland
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A